Skip to main content
Canna~Fangled Abstracts

Cannabinoids, hippocampal excitability and efficacy for the treatment of epilepsy.

By June 6, 2019June 10th, 2019No Comments
2019 Jun 6. pii: S0163-7258(19)30109-3. doi: 10.1016/j.pharmthera.2019.06.002.
[Epub ahead of print]

Abstract

Interest in cannabis and its related cannabinoids THC and CBD for use as anti-convulsant therapy has been progressively increasing. While the destigmatization of cannabis and cannabis related research have progressed in the last few decades, there are still many questions that remain answered. This review seeks to summarize the progress made in cannabis research in the past four decades and to identify possible directions for future research that are critical for the development of cannabinoid-based therapy in epilepsy.

KEYWORDS: (9)THC, Cannabidiol, Cannabis, Epilepsy, Hippocampus, Therapy

PMID: 31176695
DOI: 10.1016/j.pharmthera.2019.06.002

Publication type

Publication type

Leave a Reply